Search Results 101-110 of 23154 for B cell lymphomas

  1. Study to Evaluate the Safety and Effectiveness of Axicabtagene Ciloleucel in Combination With Utomilumab in Adults With Relapsed/Refractory Large B-cell Lymphoma - Mayo Clinic

    Histologically proven large B-cell lymphoma, including the following types defined by (Swerdlow et al, 2016): · Relapsed or chemotherapy-refractory disease, ...

  2. Follicular Lymphoma Clinical Trials - Mayo Clinic Research

    It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is overexpressed in many patients with follicular lymphoma. Venetoclax ...

  3. Study of Brentuximab Vedotin Combined With RCHOP in Front-line Treatment of Patients With Diffuse Large B-cell Lymphoma (DLBCL) - Mayo Clinic

    Study of Brentuximab Vedotin Combined With RCHOP in Front-line Treatment of Patients With Diffuse Large B-cell Lymphoma (DLBCL) · Overview · Participation ...

  4. Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas - Mayo Clinic

    ... B-Cell Non-Hodgkin Lymphomas. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information ...

  5. LymphoStats - Lymphoma Biostatistics and Data Science: Matthew J. Maurer - Mayo Clinic Research

    These models and tools have been developed by the lab or in collaboration with lab members. Prognostic models. Diffuse large B-cell lymphoma. Newly diagnosed.

  6. A Safety Study of SGN-CD19B in Patients With B-cell Non-Hodgkin Lymphoma - Mayo Clinic

    ... B-cell non-Hodgkin lymphoma (NHL) subtypes of diffuse large B-cell lymphoma (DLBCL) and Grade 3 follicular lymphoma (FL3). Additionally, the pharmacokinetic ...

  7. Anne J. Novak, Ph.D. - Mayo Clinic Faculty Profiles

    B-cell lymphomas are a heterogeneous group of neoplasms that arise from lymphocytes and produce tumors in the lymph nodes, lymphatic organs and extranodal ...

  8. A Study to Compare Tisagenlecleucel vs. Standard of Care in Adult Patients with Aggressive B-cell Non-Hodgkin Lymphoma - Mayo Clinic

    A Study to Compare Tisagenlecleucel vs. Standard of Care in Adult Patients with Aggressive B-cell Non-Hodgkin Lymphoma · Share · Facebook · Twitter.

  9. Targeted Drug with Chemotherapy Combo Offers Longer Life to Patients with B-cell Cancers - Mayo Clinic News Network

    ... cell lymphoma, a subset of B-cell lymphoma. It was also approved in February 2014 for use in CLL, following a study of the agent alone in patients with very ...

  10. Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL) - Mayo Clinic

    The purpose of this study is to determine how well SNS01-T is tolerated by relapsed or refractory multiple myeloma, B cell lymphoma or plasma cell leukemia ...